HRSA-21-124: Building the HIV Workforce and Strengthening Engagement in Communities of Color (B-SEC)
Closed
This grant is closed. A newer notice from the same program is forecast: Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance (HRSA-27-078). Status: Expected deadline January 20, 2027. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make one award worth $1.9 million in total. Applications closed on July 6, 2021.
From the official notice on Grants.gov, last changed May 20, 2021. Checked November 7, 2026.
- Total funding$1.9 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | May 20, 2021 |
|---|---|
| Deadline | July 6, 2021 |
| Archived by Grants.gov | September 4, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include public and nonprofit private entities; state and local governments; academic institutions; local health departments; nonprofit hospitals and outpatient clinics; community health centers receiving support under Section 330 of the PHS Act; faith-based and community-based organizations; and Indian Tribes or Tribal organizations with or without federal recognition
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
Minority Serving Institutions (MSIs)1 play a critical role in the nation’s response to ending the HIV epidemic by educating and preparing the next generation of leaders, health care providers, researchers, educators, and public health professionals; conducting research that helps us improve the response to the HIV epidemic; and educating their faculty, staff and communities about HIV. This notice announces the opportunity to apply for the Building the HIV Workforce and Strengthening Engagement in Communities of Color (B-SEC) pilot program. Funding under this announcement will support a cooperative agreement for a 4-year award to a single organization to address the national shortage of minority-serving providers in the HIV workforce. The award recipient will integrate topics in HIV into health-related courses and the HRSA National HIV Curriculum (NHC) into the curricula of participating, accredited, health professions programs at undergraduate MSIs. Integrating topics in HIV into the broader curriculum offers an opportunity for more students to become educated about HIV regardless of their area of study. The NHC will be tailored for the discipline and academic year of the participating students. In addition, the organization will partner with MSIs to develop and implement community engagement activities, raise awareness about the advances in HIV care and treatment, and reduce the stigma that is a barrier to care in many communities of color. The Building the HIV Workforce and Strengthening Engagement in Communities of Color (B-SEC) pilot project will leverage the long-standing presence and trusted voice of MSIs in communities of color disproportionately affected by HIV to educate and train students in HIV, raise awareness about the advances in the care and treatment of HIV, and reduce stigma.
Who has won HIV-Related Training and Technical Assistance grants before
From fiscal 2021 to 2025, HIV-Related Training and Technical Assistance (93.145) awarded $599 million across 587 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 7 | $31.0 million |
| Vanderbilt University Medical Center | Tennessee | 3 | $23.4 million |
| The Trustees of Columbia University in the City of New York | New York | 3 | $22.0 million |
| University of Illinois | Illinois | 6 | $21.7 million |
| University of Washington | Washington | 4 | $19.0 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-078, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-21-124 still open?
No. It closed on July 6, 2021. A newer notice is forecast: HRSA-27-078, expected deadline January 20, 2027.
Who can apply for Building the HIV Workforce and Strengthening Engagement in Communities of Color (B-SEC)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Building the HIV Workforce and Strengthening Engagement in Communities of Color (B-SEC)?
Closed July 6, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $1.9 million in total for one award.
Who has won HIV-Related Training and Technical Assistance grants before?
The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, Vanderbilt University Medical Center, The Trustees of Columbia University in the City of New York. The program made 587 awards worth $599 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)